|
IT1190891B
(it)
|
1982-06-24 |
1988-02-24 |
Anic Spa |
Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
|
|
US5910304A
(en)
|
1982-12-13 |
1999-06-08 |
Texas A&M University System |
Low-dose oral administration of interferons
|
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US5049386A
(en)
|
1985-01-07 |
1991-09-17 |
Syntex (U.S.A.) Inc. |
N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4946787A
(en)
|
1985-01-07 |
1990-08-07 |
Syntex (U.S.A.) Inc. |
N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
CA1320905C
(en)
|
1986-11-06 |
1993-08-03 |
Joseph M. Cummins |
Treatment of immuno-resistant disease
|
|
FI81498C
(fi)
|
1987-01-13 |
1990-11-12 |
Biocon Oy |
Kirurgiska material och instrument.
|
|
US5270171A
(en)
*
|
1987-03-06 |
1993-12-14 |
Boris Cercek |
Cancer-associated SCM-recognition factor, preparation and method of use
|
|
US5580561A
(en)
*
|
1987-03-06 |
1996-12-03 |
Cercek; Boris |
Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5693622A
(en)
|
1989-03-21 |
1997-12-02 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
US5676954A
(en)
|
1989-11-03 |
1997-10-14 |
Vanderbilt University |
Method of in vivo delivery of functioning foreign genes
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
US5981276A
(en)
|
1990-06-20 |
1999-11-09 |
Dana-Farber Cancer Institute |
Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
|
|
US5353535A
(en)
|
1990-11-05 |
1994-10-11 |
Plumly George W |
Floor type advertising apparatus
|
|
EP0667786B1
(en)
|
1992-08-27 |
2004-01-21 |
Deakin Research Limited |
Retro-, inverso-, and retro-inverso synthetic peptide analogues
|
|
WO1994005265A1
(en)
|
1992-09-10 |
1994-03-17 |
Children's Medical Center Corporation |
Biodegradable polymer matrices for sustained delivery of local anesthetic agents
|
|
EP1024198A3
(en)
|
1992-12-03 |
2002-05-29 |
Genzyme Corporation |
Pseudo-adenoviral vectors for the gene therapy of haemophiliae
|
|
US5514653A
(en)
*
|
1994-09-09 |
1996-05-07 |
Washington University |
Method of blocking the SEC receptor
|
|
US5665557A
(en)
|
1994-11-14 |
1997-09-09 |
Systemix, Inc. |
Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
|
|
AU7435296A
(en)
|
1995-10-16 |
1997-05-07 |
Dana-Farber Cancer Institute |
Novel expression vectors and methods of use
|
|
US6036949A
(en)
|
1998-03-05 |
2000-03-14 |
Amarillo Biosciences, Inc. |
Treatment of fibromyalgia with low doses of interferon
|
|
WO1999055564A1
(en)
|
1998-04-24 |
1999-11-04 |
Univ Florida |
Materials and methods for gene therapy
|
|
US20100210528A1
(en)
*
|
1999-03-05 |
2010-08-19 |
Leland Shapiro |
Compositions, methods and uses for inhibition and/or treatment of influenza infection
|
|
WO2003089011A1
(en)
|
2002-04-19 |
2003-10-30 |
University Of Florida |
rAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES
|
|
EP2520654B8
(en)
|
2003-08-26 |
2017-04-19 |
The Regents of the University of Colorado, a body corporate |
Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
|
|
US20090023643A1
(en)
|
2004-01-13 |
2009-01-22 |
Vasogenix Pharmaceuticals, Inc. |
Methods For Treating Acute Myocardial Infarction By Administering Calcitonin Gene Related Peptide And Compositions Containing The Same
|
|
DE602005013670D1
(de)
*
|
2004-05-21 |
2009-05-14 |
Inst Systems Biology |
Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
|
|
US8715649B2
(en)
|
2005-06-07 |
2014-05-06 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
|
|
BRPI0621081A2
(pt)
|
2005-12-23 |
2011-11-29 |
Vital Health Sciences Pty Ltd |
método de modulação de uma ou mais citocinas imuno-reguladoras, uso de um ou mais derivados de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos, método de inibição de uma resposta inflamatória e/ou de estimulação de uma resposta anti-inflamatória, método de tratamento e/ou de profilaxia de distúbios imunológicos, distúrbios inflamatórios e/ou distúrbios proliferativos celulares, agente imuno-modulador, agente anti-inflamatório ou agente anti-cáncer e um ou mais derivado de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos
|
|
AU2007221177A1
(en)
|
2006-02-28 |
2007-09-07 |
Trustees Of Boston University |
Methods to identify factors associated with muscle growth and uses thereof
|
|
US20080008694A1
(en)
|
2006-07-05 |
2008-01-10 |
Elgebaly Salwa A |
Methods to prevent and treat diseases
|
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
|
US20100267052A1
(en)
|
2006-09-01 |
2010-10-21 |
American Type Culture Collection |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
|
US20090203602A1
(en)
*
|
2006-09-01 |
2009-08-13 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
|
US8623830B2
(en)
|
2006-09-12 |
2014-01-07 |
Beth Israel Deaconess Medical Center, Inc. |
Compositions containing α-1-antitrypsin and methods for use
|
|
HRP20150330T1
(hr)
|
2007-08-30 |
2015-06-19 |
Curedm Group Holdings, Llc |
Pripravci i postupci uporabe prostaniäśnog peptida za stanice otoäśiä†a i njegovih analoga
|
|
US8758761B2
(en)
|
2007-09-30 |
2014-06-24 |
University Of Florida Research Foundation, Inc. |
Combination therapies for treating type 1 diabetes
|
|
US7923253B2
(en)
*
|
2007-11-05 |
2011-04-12 |
Battelle Memorial Institute |
Method for identifying type I diabetes mellitus in humans
|
|
WO2011109768A2
(en)
|
2010-03-04 |
2011-09-09 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods for modulating cardiac conditions
|
|
WO2011126882A2
(en)
*
|
2010-03-30 |
2011-10-13 |
American Type Culture Collection |
Therapeutic peptides and their derivatives and therapeutic uses thereof
|
|
US9005615B2
(en)
|
2010-05-06 |
2015-04-14 |
The Feinstein Institute For Medical Research |
Methods for treatment of inflammatory diseases
|
|
WO2013106273A2
(en)
|
2012-01-09 |
2013-07-18 |
Serpin Pharma, Llc |
Peptides and methods of using same
|
|
WO2013106589A1
(en)
|
2012-01-10 |
2013-07-18 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
WO2014197524A2
(en)
|
2013-06-06 |
2014-12-11 |
Serpin Pharma, Llc |
Peptide therapy for treatment of alpha-1 antitrypsin deficiency and associated pathologies
|
|
KR20160146242A
(ko)
|
2015-06-12 |
2016-12-21 |
현대자동차주식회사 |
터보차저 엔진의 재순환 밸브 구동 장치 및 방법
|
|
WO2017040287A1
(en)
|
2015-08-28 |
2017-03-09 |
Serpin Pharma, Llc |
Methods for treatment of diseases
|